Altered platelet and coagulation function in moderate-to-severe COVID-19
Abstract To reveal if coagulopathies relate to the course of COVID-19, we examined 255 patients with moderate and severe COVID-19, receiving anticoagulants and immunosuppressive drugs. Coagulopathy manifested predominantly as hypercoagulability that correlated directly with systemic inflammation, di...
Guardado en:
Autores principales: | Rustem I. Litvinov, Natalia G. Evtugina, Alina D. Peshkova, Svetlana I. Safiullina, Izabella A. Andrianova, Alina I. Khabirova, Chandrasekaran Nagaswami, Rafael R. Khismatullin, Svetlana S. Sannikova, John W. Weisel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/036bc870feca4d6084489ea709a4889d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Activated Monocytes Enhance Platelet-Driven Contraction of Blood Clots via Tissue Factor Expression
por: Alina D. Peshkova, et al.
Publicado: (2017) -
The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli
por: Irina N. Chernysh, et al.
Publicado: (2020) -
Quantitative structural mechanobiology of platelet-driven blood clot contraction
por: Oleg V. Kim, et al.
Publicado: (2017) -
Severe Congenital Thrombocytopenia Characterized by Decreased Platelet Sialylation and Moderate Complement Activation Caused by Novel Compound Heterozygous Variants in GNE
por: Karolina I. Smolag, et al.
Publicado: (2021) -
Coagulation disorders in patients with severe hemophagocytic lymphohistiocytosis.
por: Sandrine Valade, et al.
Publicado: (2021)